Latest Product News
The FDA has approved Tandem Diabetes new t:slim G4™ Insulin Pump, the first and only touch-screen pump with continuous glucose monitoring (CGM) integration, for use by people 12 years of age or older who use insulin. It combines features and benefits of the t:slim® Insulin Pump and Dexcom G4® PLATINUM CGM System, devices that have consistently ranked #1 in independent surveys. The t:slim G4 Pump conveniently displays CGM graphs and trend information with current insulin delivery activity together on the home screen to help make informed treatment decisions.
Please call one of our Insulin Pumps Specialists today at 888-670-7867.
The latest from Dexcom is the G5® Mobile Continuous Glucose Monitoring (CGM) System. It has wireless Bluetooth® technology built into the device transmitter, the G5 Mobile CGM System is the first and only fully mobile CGM system approved by the FDA for both adults and children as young as 2 years of age that sends glucose data directly to a smartphone, freeing users from the need to carry a separate receiver.
The new transmitter securely sends vital glucose information directly to an app on iOS-enabled devices for real-time diabetes management. Android applications will be available in early 2016. Like its predecessor, the G4 PLATINUM CGM with Share, users can select up to five designated recipients, or “followers”. These followers can remotely monitor a patient’s glucose information and receive alert notifications from almost anywhere.
Please give our CGMS specialists a call today at 888-670-7867.